Lympho Bob

I've written a lot lately about the idea of "survivorship" -- what happens after treatment is over. It's an important issu...

The FDA has approved Tafasitamab-cxix (also known as Monjuvi) in combination with Lenalidomide (also known as Revlimid) and Rituxan for Rel...

A reader left a comment on my last post that I want to address here, rather than in the comment section: Thank you for ASCO coverage. Seems ...

 As I have been saying, there really weren't a lot of presentations on Follicular Lymphoma at ASCO this year, and most of them have been...

 Before I get to another ASCO presentation, I want to provide a link to the webinar I helped with last week for the Follicular Lymphoma Foun...

As I said in my last post, this is kind of a lean year for Follicular Lymphoma at ASCO. There are far fewer presentations on FL than there h...

It's finally time to get to some ASCO reviews. As I said in my last post, there seems to be a much smaller number of presentations about...